Year None202620252024202320222021202020192018201720162015 Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences March 12, 2026 at 9:00 AM EDT Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis January 9, 2026 at 6:01 AM EST
Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences March 12, 2026 at 9:00 AM EDT
Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis January 9, 2026 at 6:01 AM EST